Agios Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US00847X1046

SecurityAGIO / Agios Pharmaceuticals, Inc.
InstitutionCreative Planning
Latest Disclosed Ownership13,333 shares
Latest Disclosed Value $ 451,055
Creative Planning ownership in AGIO / Agios Pharmaceuticals, Inc.

On May 12, 2026 - Creative Planning filed a 13F-HR form disclosing ownership of 13,333 shares of Agios Pharmaceuticals, Inc. (US:AGIO) valued at $451,055 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 10,370 shares of Agios Pharmaceuticals, Inc.. This represents a change in shares of 28.57% during the quarter. The current value of the position is $369,057 USD.

Creative Planning has a history of taking positions in derivatives of the underlying security (AGIO) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AGIO / Agios Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 13,333 2,963 28.57 451 59.93 0.0003
2026-02-17 2025-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 10,370 -2,749 -20.95 282 -46.39 0.0002
2025-11-14 2025-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 13,119 280 2.18 527 23.19 0.0004
2025-08-08 2025-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 12,839 917 7.69 427 22.35 0.0004
2025-05-15 2025-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 11,922 -1,214 -9.24 349 -19.03 0.0003
2025-02-14 2024-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 13,136 -2,504 -16.01 432 -37.90 0.0004
2024-10-11 2024-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 15,640 4,120 35.76 695 39.92 0.0007
2024-08-15 2024-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 11,520 2,276 24.62 497 83.70 0.0005
2024-05-13 2024-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 9,244 9,244 270 0.0003
2022-02-11 2021-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -5,102 -100.00 0 -100.00
2021-11-10 2021-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 5,102 0 0.00 235 -16.37 0.0004
2021-08-04 2021-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 5,102 -1 -0.02 281 6.44 0.0005
2021-04-30 2021-03-31 13F CreativePlanning COM 00847X104 5,103 -1,182 -18.81 264 -2.94 0.0005
2021-01-29 2020-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 6,285 6,285 272 0.0006
2020-11-05 2020-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -4,785 -100.00 0 -100.00
2020-07-23 2020-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 4,785 4,785 256 0.0007
2020-05-05 2020-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -4,835 -100.00 0 -100.00
2020-01-30 2019-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 4,835 4,835 231 0.0007
2019-11-01 2019-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -4,795 -100.00 0 -100.00
2019-07-26 2019-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 4,795 1,010 26.68 239 -6.27 0.0008
2019-04-24 2019-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 3,785 3,785 255 0.0009
2019-02-12 2018-12-31 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 0 -3,804 -100.00 0 -100.00
2018-10-25 2018-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 3,804 -877 -18.74 293 -25.63 0.0011
2018-07-20 2018-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 4,681 4,681 394 0.0015
2018-01-17 2017-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -16,650 -100.00 0 -100.00
2017-10-17 2017-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 16,650 -60 -0.36 1,111 29.19 0.0052
2017-07-12 2017-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 16,710 228 1.38 860 -10.70 0.0044
2017-04-07 2017-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 16,482 1,528 10.22 963 54.33 0.0053
2017-01-09 2016-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 14,954 6,875 85.10 624 46.14 0.0038
2016-10-12 2016-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 8,079 -100 -1.22 427 24.49 0.0027
2016-07-12 2016-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 8,179 -900 -9.91 343 -7.05 0.0025
2016-04-08 2016-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 9,079 -6 -0.07 369 -37.46 0.0029
2016-01-11 2015-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 9,085 5,000 122.40 590 104.86 0.0049
2015-10-09 2015-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 4,085 4,085 0.00 288 0.0025
2015-07-09 2015-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -2,079 -100.00 0 -100.00
2015-04-13 2015-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 2,079 2,079 0.00 196 0.0018
2015-01-29 2014-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -1,050 -100.00 0 -100.00
2014-10-10 2014-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 1,050 1,050 64 0.0007
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2016-10-12 2016-09-30 13F AGIOS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-07-12 2016-06-30 13F AGIOS PHARMACEUTICALS COM Put 100 1 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.